GlassScriptPhysician profile
Paola Suarez
NPI 1326221698
$558.02
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $28.70 · 2021: $53.66 · 2022: $121 · 2023: $175 · 2024: $50.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $207.28 | 2019-2023 | Bexsero, Rotarix, Pediarix |
| Cranial Technologies, INC | $85.76 | 2021-2024 | Doc Band |
| Pfizer INC. | $63.87 | 2019-2022 | |
| Seqirus USA INC | $56.73 | 2019 | |
| Sanofi Pasteur INC. | $52.64 | 2021-2023 | |
| Abbott Laboratories | $30.76 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $28.29 | 2022 | |
| Novo Nordisk INC | $19.24 | 2024 | Rybelsus, Ozempic |
| Dexcom, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paola Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.